Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Rheumatoid Arthritis

  Free Subscription


Articles published in Drugs

Retrieve available abstracts of 10 articles:
HTML format
Text format



Single Articles


    June 2018
  1. LAMB YN, Deeks ED
    Sarilumab: A Review in Moderate to Severe Rheumatoid Arthritis.
    Drugs. 2018;78:929-940.
    PubMed     Text format     Abstract available


    April 2018
  2. AL-SALAMA ZT, Scott LJ
    Baricitinib: A Review in Rheumatoid Arthritis.
    Drugs. 2018 Apr 23. pii: 10.1007/s40265-018-0908.
    PubMed     Text format     Abstract available


    December 2017
  3. SCOTT LJ
    Correction to: Tocilizumab: A Review in Rheumatoid Arthritis.
    Drugs. 2017 Dec 19. pii: 10.1007/s40265-017-0856.
    PubMed     Text format     Abstract available


    November 2017
  4. DHILLON S
    Tofacitinib: A Review in Rheumatoid Arthritis.
    Drugs. 2017 Nov 14. doi: 10.1007/s40265-017-0835.
    PubMed     Text format     Abstract available


  5. SCOTT LJ
    Tocilizumab: A Review in Rheumatoid Arthritis.
    Drugs. 2017 Nov 1. doi: 10.1007/s40265-017-0829.
    PubMed     Text format     Abstract available


    June 2017
  6. BLAIR HA, Deeks ED
    Abatacept: A Review in Rheumatoid Arthritis.
    Drugs. 2017 Jun 12. doi: 10.1007/s40265-017-0775.
    PubMed     Text format     Abstract available


    April 2017
  7. SCOTT LJ
    Sarilumab: First Global Approval.
    Drugs. 2017;77:705-712.
    PubMed     Text format     Abstract available


  8. MARKHAM A
    Baricitinib: First Global Approval.
    Drugs. 2017;77:697-704.
    PubMed     Text format     Abstract available


    November 2016
  9. BRITO-ZERON P, Retamozo S, Gheitasi H, Ramos-Casals M, et al
    Treating the Underlying Pathophysiology of Primary Sjogren Syndrome: Recent Advances and Future Prospects.
    Drugs. 2016;76:1601-1623.
    PubMed     Text format     Abstract available


    September 2016
  10. GECSE KB, Lakatos PL
    Biosimilar Monoclonal Antibodies for Inflammatory Bowel Disease: Current Comfort and Future Prospects.
    Drugs. 2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: